跳至主要内容
ProhibitedBinding ruleGBOriginal is English已检查官方来源导入

Bretylium tosilate (INN)

The consolidated GB Cosmetics Regulation lists this record in Annex II.

监管决定及完整条件

状态
Prohibited
法律地位
Binding rule
监管摘要
The consolidated GB Cosmetics Regulation lists this record in Annex II.
条件与限制
A prohibition entry may contain no separate condition text because the regulatory outcome is the prohibition itself. 请打开所引用的来源,并适用下方的全市场要求。

物质身份

官方来源名称
Bretylium tosilate (INN)
CAS
61-75-6
EC
200-516-8
身份映射
standalone:official_gb_annex

该身份的跨市场概览

本站目前已有的精确关联记录。某市场缺失表示没有已导入的精确匹配,并不表示准许使用该物质。

10 个市场数据集
CAS 61-75-6 的 PubChem 二维化学结构
CAS 61-75-6PubChem CID 6100

CAS 61-75-6 的已核实化学信息

Bretylium Tosylate

Bretylium tosylate is the tosylate salt of bretylium. It blocks noradrenaline release from the peripheral sympathetic nervous system, and is used in emergency medicine, cardiology, and other specialties for the acute management of ventricular tachycardia and ventricular fibrillation. It has a role as an antihypertensive agent, an adrenergic antagonist and an anti-arrhythmia drug. It is a quaternary ammonium salt and an organosulfonate salt. It contains a bretylium. — ChEBI

IUPAC 名称
(2-bromophenyl)methyl-ethyl-dimethylazanium;4-methylbenzenesulfonate
分子式
C18H24BrNO3S
分子量
414.4 g/mol
精确质量
413.06603 Da
单同位素质量
413.06603 Da
拓扑极性表面积
65.6 Ų
分子复杂度
349.0
形式电荷
0
氢键供体
0
氢键受体
3
可旋转键
3
重原子
24
共价单元
2

向 PubChem 报告的名称和同义词

BretylolBretylium tosilateDarentinTosilato de bretilioTosilate de bretyliumBretylii tosilasASL-603(o-Bromobenzyl)ethyldimethylammonium p-toluenesulfonate
另有 16 个已报告名称
Bretilio tosilatoBretylium Tosylate In Dextrose 5%NSC-621642-Bromo-N-ethyl-N,N-dimethylbenzenemethanaminium 4-methylbenzenesulfonateDimethylethyl-o-bromobenzylammonium-p-toluenesulphonateN-Ethyl-N-o-bromobenzyl-N,N-dimethylammonium tosylate78ZP3YR353Benzenemethanaminium, 2-bromo-N-ethyl-N,N-dimethyl-, salt with 4-methylbenzenesulfonic acid (1:1)CHEBI:3173BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINERbrAtylium (cation)RefChem:56963C01BD02200-516-8OrnidBretylate
外部数据库标识符
高级结构统计
已定义的原子立体中心
0
未定义的原子立体中心
0
已定义的键立体中心
0
未定义的键立体中心
0
三维构象异构体
0
机器可读的结构标识符
SMILES
CC[N+](C)(C)CC1=CC=CC=C1Br.CC1=CC=C(C=C1)S(=O)(=O)[O-]
InChI
InChI=1S/C11H17BrN.C7H8O3S/c1-4-13(2,3)9-10-7-5-6-8-11(10)12;1-6-2-4-7(5-3-6)11(8,9)10/h5-8H,4,9H2,1-3H3;2-5H,1H3,(H,8,9,10)/q+1;/p-1
InChIKey
KVWNWTZZBKCOPM-UHFFFAOYSA-M

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

官方来源与出处

已登记来源
Great Britain Cosmetics Regulation — consolidated Annexes II–VI and amendments
来源参考
GB Cosmetics Regulation, Annex II, entry 56
来源记录 ID
II-56
来源版本
2026-08-15
来源语言
English
翻译状态
Original is English
生效日期
2026-08-15
来源更新
2026-08-19
快照检查时间
2026-08-30 04:51 UTC
验证方法
legislation.gov.uk XML table parse; {'II': 1758, 'III': 326, 'IV': 154, 'V': 57, 'VI': 34}
SHA-256
e3a386d950f54c6e7a7f9e784d1bd46e52de725137e89d5630709824475215d8

已登记的数据集备注

数据集覆盖范围
Complete consolidated GB Annexes II–VI, with later amendments versioned separately
权威性说明
Binding GB schedules and versioned amendments to retained Regulation 1223/2009; applies to England, Wales and Scotland, not Northern Ireland
来源许可
Open Government Licence v3.0 / Crown copyright
署名
Contains public sector information licensed under the Open Government Licence v3.0.

本记录在市场数据集中的位置

2329
条当前 Great Britain 记录
1758
条标记为 Prohibited 的记录
2329
条来自此来源版本的记录
2015
条带有 CAS 身份的市场记录

状态分布

在 2329 条当前记录中,有 517 条带有条件文本。条件字段为空时,按上述记录类型解释;绝不会被转换为可无限制使用的声明。

Great Britain 市场背景

Complete consolidated annex dataset

覆盖版本: GB retained Regulation 1223/2009 schedules, effective 15 August 2026

Current consolidated Annexes II–VI for England, Scotland and Wales.

核实清单

  1. Confirm INCI/CAS/EC identity.
  2. Review every current GB Annex II–VI match.
  3. Check commencement dates and later statutory instruments.
  4. Verify SCPN, responsible-person, safety-report and labelling duties.

官方市场来源

核实工作流程与记录完整性

在将此结果用于合规决定之前

  1. 确认“Bretylium tosilate (INN)”及每个 CAS/EC 标识符所指的物料与您的供应商规格一致。
  2. Confirm INCI/CAS/EC identity.
  3. Review every current GB Annex II–VI match.
  4. Check commencement dates and later statutory instruments.
  5. Verify SCPN, responsible-person, safety-report and labelling duties.
  6. 记录来源版本,并在生产、备案或上市之前重新核查监管机构。

本记录中的可用字段

  • 官方物质名称可用
  • CAS可用
  • EC可用
  • 单独的条件文本来源行中不存在
  • 生效日期可用
  • 快照哈希与方法可用

本页回答的问题

This official record identifies the substance as prohibited for cosmetic use in the stated market scope. Do not rely on a formulation containing this identity until the cited source, effective date and exact substance match have been verified.

A prohibition entry may contain no separate condition text because the regulatory outcome is the prohibition itself. No annex match is not approval and does not cover Northern Ireland, which follows the applicable EU framework.

该记录引用 GB Cosmetics Regulation, Annex II, entry 56,来源版本 2026-08-15。 打开官方来源。

不保证。CAS 有助于确定身份,但各辖区可能对同一物质作出不同分类,并可能适用不同的产品范围、限值、警示语和过渡日期。

稳定引用

Bretylium tosilate (INN). GB Cosmetics Regulation, Annex II, entry 56. Great Britain. Source version 2026-08-15. CosIng Checker regulatory record: https://cosingchecker.com/zh-hans/regulations/gb/records/4413/

请将监管机构作为法律依据来引用。本页是结构化的证据索引和核实辅助工具,不能替代官方文本或专业法律评估。

Great Britain 的解读与局限

This official record identifies the substance as prohibited for cosmetic use in the stated market scope.

Do not rely on a formulation containing this identity until the cited source, effective date and exact substance match have been verified.

如何解读法律地位

The cited row forms part of a binding rule or legally incorporated list for this market.

本页证据

  • 记录结果:Prohibited
  • 法律地位:Binding rule
  • 来源版本:2026-08-15
  • 生效日期:2026-08-15

它不能证明什么

No annex match is not approval and does not cover Northern Ireland, which follows the applicable EU framework.

进一步的权威物质研究

这些来源均不能推翻上述市场决定。

Cosmetic Ingredient Review safety assessments

Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents

Independent expert review considered by FDA; not a government approval or binding market rule

在来源处研究此身份

FDA Global Substance Registration System

UNII identifiers, preferred names, substance types, codes and public substance relationships

Identity registry only; UNII availability does not imply FDA review or approval

在来源处研究此身份

ILO/WHO International Chemical Safety Cards

Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals

International occupational chemical-safety reference; not cosmetic-use approval

在来源处研究此身份

Japan NITE-CHRIP

Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information

Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules

在来源处研究此身份

NIOSH Pocket Guide to Chemical Hazards

REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals

US occupational-health guidance and limits; not a cosmetic ingredient decision

在来源处研究此身份

OECD eChemPortal

Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records

Discovery gateway; each linked authority remains responsible for its data

在来源处研究此身份

US EPA CompTox CTX APIs

导入需要 API 密钥

DTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data

Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality

在来源处研究此身份